Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 10, 2021
Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification.
Journal: Breast cancer research and treatment
Published: November 15, 2017
Showing 1-2 of 2
Last Updated: 09/26/2026